Blue Crest Capital Management LTD Sage Therapeutics, Inc. Transaction History

Blue Crest Capital Management LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$89.33 - $163.65 $238,064 - $436,127	-2,665 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$81.94 - $139.71 $1.7 Million - $2.9 Million	-20,789 Reduced 88.64%	2,665 $255,000
Q3 2018 Nov 14, 2018	SELL	$138.11 - $169.04 $6.1 Million - $7.47 Million	-44,194 Reduced 65.33%	23,454 $3.31 Million
Q2 2018 Aug 14, 2018	BUY	$140.36 - $175.76 $9.19 Million - $11.5 Million	65,501 Added 3050.82%	67,648 $10.6 Million
Q1 2018 May 15, 2018	BUY	$152.15 - $192.33 $326,666 - $412,932	2,147 New	2,147 $346,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.